Substance
ID:329164
Names and Identifiers
IUPAC name
(4-carboxybutyl)triphenylphosphanium bromide
IUPAC Traditional name
(4-carboxybutyl)triphenylphosphanium bromide
Synonyms
NSC 1477565-(Triphenylphosphonio)pentanoic acid bromideCarboxybutyltriphenylphosphonium bromide(4-羧丁基)三苯基溴化膦(4-Carboxybutyl)triphenylphosphonium bromide
Registration numbers
CAS Number
EC Number
MDL Number
Beilstein Number
PubChem SID
Properties
Product Information
Linear Formula
(C6H5)3P(Br)(CH2)4COOH
Purity
98%
Safety Information
European Hazard Symbols
Irritant (Xi)GHS Precautionary statements
P261-P305+P351+P338
Risk Statements
36/37/38
German water hazard class
3
GHS Signal Word
Warning
GHS Hazard statements
H315-H319-H335
Safety Statements
26-36
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
MSDS Link
GHS Pictograms
Acute toxicity (oral, dermal, inhalation), category 4
Skin irritation, category 2
Eye irritation, category 2
Skin sensitisation, category 1
Specific Target Organ Toxicity – Single exposure, category 3
Physical Property
Melting Point
204-207 °C(lit.)
Molecule Details
Packaging
10, 50, 250 g in poly bottle
Application
• Used as a platform for delivery of pro-apoptotic peptides into the mitochondria of tumor cells1Reactant for preparation of:
• Ring skeletons via ring closing metathesis and double bond migration ring closing metathesis reactions2
• Methyl alkenyl quinolones as antimycobacterial agents3
• Prostaglandins and their drug analogs via Gold-catalyzed Meyer-Schuster rearrangement4
• Diphenylmethylpiperazines as N-type calcium channel blockers as potential therapeutic agents5
• Folate receptor-specific glycinamide ribonucleotide formyltransferase (GARFTase) inhibitors with antitumor activity6
• Cycloalkylidene alkanols with antileishmanial activity, via Wittig reaction7
10, 50, 250 g in poly bottle
Application
• Used as a platform for delivery of pro-apoptotic peptides into the mitochondria of tumor cells1Reactant for preparation of:
• Ring skeletons via ring closing metathesis and double bond migration ring closing metathesis reactions2
• Methyl alkenyl quinolones as antimycobacterial agents3
• Prostaglandins and their drug analogs via Gold-catalyzed Meyer-Schuster rearrangement4
• Diphenylmethylpiperazines as N-type calcium channel blockers as potential therapeutic agents5
• Folate receptor-specific glycinamide ribonucleotide formyltransferase (GARFTase) inhibitors with antitumor activity6
• Cycloalkylidene alkanols with antileishmanial activity, via Wittig reaction7
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data